A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Title

Code

AL-DES 01_RINGSIDE

Type

Sperimentale con farmaco

Start Year

2023

Status

In progress

Principal Investigator

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. AL-DES 01_RINGSIDE

Tuesday 25 July 2023, 13:34

PG0010955_2023_Stampa_unica.pdf

You might also be interested in

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Principal Investigator

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Principal Investigator

Documents and Videos attachament

You might also be interested in